ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

KALV KalVista Pharmaceuticals Inc

12.13
-0.04 (-0.33%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
KalVista Pharmaceuticals Inc KALV NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.04 -0.33% 12.13 15:35:11
Open Price Low Price High Price Close Price Previous Close
12.24 11.955 12.48 12.13 12.17
more quote information »

Recent News

Date Time Source Heading
5/02/202405:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
5/01/202405:30BWKalVista Pharmaceuticals Highlights Strategic Plans for..
4/22/202405:30BWKalVista Pharmaceuticals Appoints William C. Fairey to Board..
4/03/202405:30BWKalVista Pharmaceuticals to Present at 23rd Annual Needham..
4/02/202405:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
3/18/202405:30BWKalVista Pharmaceuticals Presents Real-World Data on Burden..
3/12/202405:30BWKalVista Pharmaceuticals Awarded UK Promising Innovative..
3/11/202415:37EDGAR2Form 8-K - Current report
3/11/202415:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
3/11/202405:30BWKalVista Pharmaceuticals Reports Third Fiscal Quarter..
3/08/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202405:30BWKalVista Pharmaceuticals to Present HAE Attack Journey Data..
3/07/202405:38EDGAR2Form 8-K - Current report
3/07/202405:30BWKalVista Pharmaceuticals Announces Appointment of Benjamin..
3/06/202405:30BWKalVista Pharmaceuticals to Participate in the Leerink..
3/04/202405:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..
2/27/202405:30BWKalVista Pharmaceuticals Presents Data on Unmet Needs in HAE..
2/26/202405:30BWKalVista Pharmaceuticals Presents Additional Phase 3..
2/22/202415:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202412:22EDGAR2Form SC 13D/A - General statement of acquisition of..
2/21/202420:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202420:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202420:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202420:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202420:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202415:49EDGAR2Form SC 13D/A - General statement of acquisition of..
2/20/202405:30BWKalVista Pharmaceuticals Awarded UK Innovation Passport for..
2/16/202415:32EDGAR2Form 8-K - Current report
2/16/202415:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/16/202415:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202415:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202415:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/16/202405:30BWKalVista Pharmaceuticals to Present Phase 3 Sebetralstat..
2/15/202405:30BWKalVista Pharmaceuticals Announces Pricing of a $160.1..
2/14/202419:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202416:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2/14/202415:18BWKalVista Pharmaceuticals Announces Proposed Public Offering..
2/14/202415:14EDGAR2Form 8-K - Current report
2/13/202408:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202408:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202408:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202408:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202408:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/13/202405:55EDGAR2Form 8-K - Current report
2/13/202405:30BWKalVista Pharmaceuticals Reports Phase 3 KONFIDENT Trial..
2/12/202419:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/08/202419:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202405:30BWKalVista Pharmaceuticals Reports Inducement Grants Under..

Your Recent History

Delayed Upgrade Clock